Nigel has held senior strategic and operational roles working with 3 of the World’s Top 10 Biopharmaceutical Companies, including Pfizer, with responsibilities for the USA, Europe, Africa & the Middle East, Latin America and Asia. Nigel was also a Member of the Comite de Directeurs at Sanofi and a Member of the European and North American Executive Committee.
He is a past Nonexecutive Director of the U.K. Government’s Porton Biopharma ; Chronos Therapeutics ( Oxford ) Ltd and the nominated Wellcome Trust Director of several Biotechnology Companies.
Nigel is the former President of the British Pharmaceutical Association ( ABPI ) ; a Member of the South Australian Health Board; the Confederation of British Industry President’s Committee; the UK’s Government Business, Innovation & Skills (BEIS) Advisory Board; Chair of the UK’s Life Sciences Board and Chair of the European Medicine’s Group.
In addition, he holds several Global, Academic, Board and Charity Trustee Positions.